A diagnosis of SLE was then established based on the patient’s history and positivity of anti-nuclear antibodies, anti-double stranded DNA, anti-beta-2 glycoprotein IgM, and anti-cardiolipin IgM, in addition to low complement levels. The gene discussed is CD40LG; the disease is systemic lupus erythematosus.